HCA Healthcare, Inc. (NYSE:HCA) Stake Lowered by OneAscent Financial Services LLC

OneAscent Financial Services LLC lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 10.5% in the 1st quarter, Holdings Channel reports. The firm owned 1,854 shares of the company’s stock after selling 217 shares during the quarter. OneAscent Financial Services LLC’s holdings in HCA Healthcare were worth $619,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Apexium Financial LP acquired a new stake in shares of HCA Healthcare in the 4th quarter valued at $361,000. Sanders Capital LLC lifted its position in HCA Healthcare by 4.2% during the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after acquiring an additional 456,738 shares during the last quarter. Todd Asset Management LLC lifted its position in HCA Healthcare by 17.2% during the 4th quarter. Todd Asset Management LLC now owns 226,563 shares of the company’s stock worth $61,326,000 after acquiring an additional 33,271 shares during the last quarter. KBC Group NV lifted its position in HCA Healthcare by 60.6% during the 4th quarter. KBC Group NV now owns 365,984 shares of the company’s stock worth $99,065,000 after acquiring an additional 138,146 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky lifted its position in HCA Healthcare by 15.6% during the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 199,209 shares of the company’s stock worth $53,922,000 after acquiring an additional 26,919 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Down 6.4 %

HCA Healthcare stock opened at $321.28 on Friday. The company has a market cap of $84.15 billion, a P/E ratio of 16.02, a price-to-earnings-growth ratio of 1.49 and a beta of 1.69. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $344.20. The company has a fifty day simple moving average of $325.96 and a 200 day simple moving average of $317.82. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 26th. The company reported $5.36 EPS for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. The firm had revenue of $17.34 billion during the quarter, compared to analysts’ expectations of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The company’s revenue for the quarter was up 11.2% compared to the same quarter last year. During the same quarter last year, the company posted $4.93 earnings per share. Research analysts anticipate that HCA Healthcare, Inc. will post 20.92 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Friday, June 14th were paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.82%. The ex-dividend date of this dividend was Friday, June 14th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Insider Transactions at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 1,863 shares of the firm’s stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the sale, the senior vice president now owns 19,612 shares in the company, valued at approximately $6,397,042.16. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,863 shares of HCA Healthcare stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total value of $607,673.34. Following the completion of the sale, the senior vice president now owns 19,612 shares in the company, valued at approximately $6,397,042.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 1,600 shares of HCA Healthcare stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the sale, the executive vice president now owns 34,124 shares of the company’s stock, valued at approximately $10,544,316. The disclosure for this sale can be found here. In the last 90 days, insiders sold 12,397 shares of company stock worth $3,921,929. 1.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Oppenheimer upped their target price on shares of HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a research note on Monday, April 29th. TD Cowen cut their target price on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a report on Tuesday, April 30th. Deutsche Bank Aktiengesellschaft increased their target price on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a report on Friday. JPMorgan Chase & Co. increased their target price on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a report on Thursday, May 30th. Finally, Robert W. Baird began coverage on shares of HCA Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 target price on the stock. Four research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $326.53.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.